Article

Laser vision correction after cataract surgery may correct ametropia

Washington, DC &#8212 Could laser vision correction be a safer alternative to IOL exchange in patients with ametropia after cataract surgery? That is the question that Irene C. Kuo, MD, and her colleagues tried to answer in a small study of patients who underwent LASIK or PRK to correct this problem.

April 18 - Washington, DC - Could laser vision correction be a safer alternative to IOL exchange in patients with ametropia after cataract surgery? That is the question that Irene C. Kuo, MD, and her colleagues tried to answer in a small study of patients who underwent LASIK or PRK to correct this problem.

Dr. Kuo presented the results of a retrospective, non-comparative study of 10 cataract surgery patients, including 7 men and 3 women, who had undergone laser refractive surgery for postoperative cataract surgery ametropia. Patients' charts showed that patients' average age was 75 and the average time between cataract surgery and laser surgery was 47 months. All the patients were implanted with a 3-piece PMMA lens except for 1 patient.

Nine patients had wanted to achieve emmetropia after cataract surgery. One patient had wanted monovision but the correction was -3 D. Patients were treated with the VISX excimer laser and the Bausch & Lomb Hansatome or AMO Amadeus keratome between Jan. 1, 1997 and Oct. 1, 2004.

The mean uncorrected visual acuity (UCVA) prior to laser vision correction was 20/400 and after PRK or LASIK, UCVA improved to 20/30. The median best spectacle-corrected visual acuity (BSCVA) was 20/25 and remained at that level after laser vision correction, Dr. Kuo noted.

IOL exchange can be problematic because it can lead to inflammation, corneal decompensation, glaucoma, and cystoid macular edema, she emphasized.

"Excimer laser surgery was a safe, effective off-label surgical method to correct ametropia after cataract surgery in a small series of elderly patients with short follow-up," Dr. Kuo said.

"In the future, one might be interested in looking at custom ablation, especially since this is now available. Longer follow-up and randomization of patients would be helpful. We should also be aware of how age affects corneal would healing," she concluded.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
Shehzad Batliwala, DO, aka Dr. Shehz, discussed humanitarian ophthalmology and performing refractive surgery in low-resource, high-risk areas at the ASCRS Foundation Symposium.
(Image credit: Ophthalmology Times) ASCRS 2025: Advancing vitreous care with Inder Paul Singh, MD
(Image credit: Ophthalmology Times) The Residency Report: Study provides new insights into USH2A target end points
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
© 2025 MJH Life Sciences

All rights reserved.